Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cellsMoiez Ali, Kris C. Wood, Min Lu et al.|Science Translational Medicine|2022Cited by 45
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Justine C. Rutter et al.|Nature Cancer|2022Cited by 42
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader moleculeLoïs Kelly, Alexandre Puissant, Bérangère Lombard et al.|Nature Cancer|2024Cited by 25
Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13Hazel X. Ang, Kris C. Wood, Natalia Sutiman et al.|Proceedings of the National Academy of Sciences|2023Cited by 16
CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in <i>PIK3CA</i> -Mutant Gastric CancerLyla J. Stanland, Micah A. Luftig, Hazel X. Ang et al.|Molecular Cancer Research|2023Cited by 13